Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
Identifieur interne :
003175 ( PascalFrancis/Curation );
précédent :
003174;
suivant :
003176
Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
Auteurs : D. T. Dexter [
Royaume-Uni] ;
A. E. Holley ;
W. D. Flitter ;
T. F. Slater ;
F. R. Wells ;
S. E. Daniel ;
A. J. Lees ;
P. Jenner [
Royaume-Uni] ;
C. D. MarsdenSource :
-
Movement disorders [ 0885-3185 ] ; 1994.
RBID : Pascal:94-0184234
Descripteurs français
English descriptors
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 9 |
---|
A06 | | | | @2 1 |
---|
A08 | 01 | 1 | ENG | @1 Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study |
---|
A11 | 01 | 1 | | @1 DEXTER (D. T.) |
---|
A11 | 02 | 1 | | @1 HOLLEY (A. E.) |
---|
A11 | 03 | 1 | | @1 FLITTER (W. D.) |
---|
A11 | 04 | 1 | | @1 SLATER (T. F.) |
---|
A11 | 05 | 1 | | @1 WELLS (F. R.) |
---|
A11 | 06 | 1 | | @1 DANIEL (S. E.) |
---|
A11 | 07 | 1 | | @1 LEES (A. J.) |
---|
A11 | 08 | 1 | | @1 JENNER (P.) |
---|
A11 | 09 | 1 | | @1 MARSDEN (C. D.) |
---|
A14 | 01 | | | @1 King's coll. London, biomedical sci. div., pharmacology group @2 London SW3 6LX @3 GBR @Z 1 aut. @Z 8 aut. |
---|
A20 | | | | @1 92-97 |
---|
A21 | | | | @1 1994 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000024901500130 |
---|
A44 | | | | @0 0000 |
---|
A45 | | | | @0 20 ref. |
---|
A47 | 01 | 1 | | @0 94-0184234 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B17G |
---|
C03 | 01 | X | FRE | @0 Parkinson maladie |
---|
C03 | 01 | X | ENG | @0 Parkinson disease |
---|
C03 | 01 | X | SPA | @0 Parkinson enfermedad |
---|
C03 | 02 | X | FRE | @0 Exploration |
---|
C03 | 02 | X | ENG | @0 Exploration |
---|
C03 | 02 | X | SPA | @0 Exploración |
---|
C03 | 03 | X | FRE | @0 Homme |
---|
C03 | 03 | X | ENG | @0 Human |
---|
C03 | 03 | X | SPA | @0 Hombre |
---|
C03 | 04 | X | FRE | @0 Autopsie |
---|
C03 | 04 | X | ENG | @0 Autopsy |
---|
C03 | 04 | X | SPA | @0 Autopsia |
---|
C03 | 05 | X | FRE | @0 Chromatographie HPLC |
---|
C03 | 05 | X | ENG | @0 HPLC chromatography |
---|
C03 | 05 | X | SPA | @0 Cromatografía HPLC |
---|
C03 | 06 | X | FRE | @0 Hydroperoxyde |
---|
C03 | 06 | X | ENG | @0 Hydroperoxide |
---|
C03 | 06 | X | SPA | @0 Hidroperóxido |
---|
C03 | 07 | X | FRE | @0 Lipide |
---|
C03 | 07 | X | ENG | @0 Lipids |
---|
C03 | 07 | X | SPA | @0 Lípido |
---|
C03 | 08 | X | FRE | @0 Substance grise |
---|
C03 | 08 | X | ENG | @0 Grey matter |
---|
C03 | 08 | X | SPA | @0 Substancia gris |
---|
C07 | 01 | X | FRE | @0 Système nerveux pathologie |
---|
C07 | 01 | X | ENG | @0 Nervous system diseases |
---|
C07 | 01 | X | SPA | @0 Sistema nervioso patología |
---|
N21 | | | | @1 090 |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003649
Links to Exploration step
Pascal:94-0184234
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study</title>
<author><name sortKey="Dexter, D T" sort="Dexter, D T" uniqKey="Dexter D" first="D. T." last="Dexter">D. T. Dexter</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>King's coll. London, biomedical sci. div., pharmacology group</s1>
<s2>London SW3 6LX</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Holley, A E" sort="Holley, A E" uniqKey="Holley A" first="A. E." last="Holley">A. E. Holley</name>
</author>
<author><name sortKey="Flitter, W D" sort="Flitter, W D" uniqKey="Flitter W" first="W. D." last="Flitter">W. D. Flitter</name>
</author>
<author><name sortKey="Slater, T F" sort="Slater, T F" uniqKey="Slater T" first="T. F." last="Slater">T. F. Slater</name>
</author>
<author><name sortKey="Wells, F R" sort="Wells, F R" uniqKey="Wells F" first="F. R." last="Wells">F. R. Wells</name>
</author>
<author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">A. J. Lees</name>
</author>
<author><name sortKey="Jenner, P" sort="Jenner, P" uniqKey="Jenner P" first="P." last="Jenner">P. Jenner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>King's coll. London, biomedical sci. div., pharmacology group</s1>
<s2>London SW3 6LX</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">94-0184234</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 94-0184234 INIST</idno>
<idno type="RBID">Pascal:94-0184234</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003649</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003175</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study</title>
<author><name sortKey="Dexter, D T" sort="Dexter, D T" uniqKey="Dexter D" first="D. T." last="Dexter">D. T. Dexter</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>King's coll. London, biomedical sci. div., pharmacology group</s1>
<s2>London SW3 6LX</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Holley, A E" sort="Holley, A E" uniqKey="Holley A" first="A. E." last="Holley">A. E. Holley</name>
</author>
<author><name sortKey="Flitter, W D" sort="Flitter, W D" uniqKey="Flitter W" first="W. D." last="Flitter">W. D. Flitter</name>
</author>
<author><name sortKey="Slater, T F" sort="Slater, T F" uniqKey="Slater T" first="T. F." last="Slater">T. F. Slater</name>
</author>
<author><name sortKey="Wells, F R" sort="Wells, F R" uniqKey="Wells F" first="F. R." last="Wells">F. R. Wells</name>
</author>
<author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">A. J. Lees</name>
</author>
<author><name sortKey="Jenner, P" sort="Jenner, P" uniqKey="Jenner P" first="P." last="Jenner">P. Jenner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>King's coll. London, biomedical sci. div., pharmacology group</s1>
<s2>London SW3 6LX</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autopsy</term>
<term>Exploration</term>
<term>Grey matter</term>
<term>HPLC chromatography</term>
<term>Human</term>
<term>Hydroperoxide</term>
<term>Lipids</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Exploration</term>
<term>Homme</term>
<term>Autopsie</term>
<term>Chromatographie HPLC</term>
<term>Hydroperoxyde</term>
<term>Lipide</term>
<term>Substance grise</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>DEXTER (D. T.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HOLLEY (A. E.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FLITTER (W. D.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SLATER (T. F.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>WELLS (F. R.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>DANIEL (S. E.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>LEES (A. J.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>JENNER (P.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>MARSDEN (C. D.)</s1>
</fA11>
<fA14 i1="01"><s1>King's coll. London, biomedical sci. div., pharmacology group</s1>
<s2>London SW3 6LX</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>92-97</s1>
</fA20>
<fA21><s1>1994</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000024901500130</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>94-0184234</s0>
</fA47>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Exploration</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Exploration</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Exploración</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Autopsie</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Autopsy</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Autopsia</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chromatographie HPLC</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>HPLC chromatography</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cromatografía HPLC</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Hydroperoxyde</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Hydroperoxide</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hidroperóxido</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Lipide</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Lipids</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Lípido</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Substance grise</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Grey matter</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Substancia gris</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC07>
<fN21><s1>090</s1>
</fN21>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003175 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003175 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:94-0184234
|texte= Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | |